Flagellate dermatitis in an HIV patient with Hodgkin lymphoma
DOI:
https://doi.org/10.29176/2590843X.1400Keywords:
Bleomycin, chemotherapy, adverse drug reaction.Abstract
Flagellated dermatitis is frequently associated with adverse reactions to drugs such as bleomycin, a chemotherapeutic agent, used in the treatment of lymphoproliferative disorders and germ cell tumors. The worldwide incidence of flagellated dermatitis is 8% to 22% in the population receiving bleomycin, however, the prevalence and incidence data in HIV positive patients are unknown, and there are only a few case reports in the scientific literature. We present an HIV positive patient with Hodgkin lymphoma who consulted for the appearance of skin lesions related to the initiation of treatment with bleomycin.
Author Biographies
Diana Alejandra Sandoval
Residente de Dermatología, Fundación Universitaria Sanitas, Hospital Universitario Centro Dermatológico “Federico Lleras Acosta”, E.S.E., Bogotá D.C., Colombia
John Elkin Pedraza
Residente de Dermatología, Fundación Universitaria Sanitas, Hospital Universitario Centro Dermatológico “Federico Lleras Acosta”, E.S.E., Bogotá D.C., Colombia
José Ricardo Ruiz
Médico Dermatólogo, Universidad del Bosque, Bogotá D.C., Colombia
References
Kabel A, Moharm F. Insights into dermatological applications and cutaneous toxicities of bleomycin. M J Derm. 2017;2(1):1-6.
Diao YD, Goodall J. Bleomycin-induced flagellate dermatitis. CMAJ. 2012;184(11):1280.
https://doi.org/10.1503/cmaj.111889
Ziemer M, Goetze S, Juhasz K, Elsner P. Flagellate dermatitis as a bleomycin-specific adverse effect of cytostatic therapy: A clinical-histopathologic correlation. Am J Clin Dermatol. 2011;12(1):68-76.
https://doi.org/10.2165/11537080-000000000-00000
Vennepureddy A, Siddique MN, Odaimi M, Terjanian T. Bleomycin-induced flagellate erythema in a patient with Hodgkin's lymphoma - A case report and review of literature. J Oncol Pharm Pract. 2015;22(3):556-60.
https://doi.org/10.1177/1078155215580468
Schummer C, Winkler Y, Tittelbach J, Grimm MO, Elsner P. Flagellanten-Dermatitis nach Bleomycingabe bei einem Patienten mit malignem Keimzelltumor. Dtsch Med Wochenschr. 2014;139(3):84-6.
https://doi.org/10.1055/s-0033-1359878
Kruk D, Sawka C. Bleomycin dermatologic toxicity in a patient with HIV-associated sarcoma. Can J Hosp Pharm. 1997;50(2):77-8.
Eungdamrong J, McLellan B. Flagellate erythema. Dermatol Online J. 2013;19(12):20716.
Soto Febles C, Febles Fernández C, Saldaña Bernabeu A, García Triana BE. Fenómenos oxidativos asociados con la infección por VIH/Sida. Rev Cuba Invest Biomed. 2002;21(3):201-6.
Pomier O, Gil L, Rodríguez F, Huetes L, Alerm A, Bermúdez A, et al. Indicadores del estrés oxidativo en pacientes afectados por VIH/sida con manifestaciones reumatológicas. Rev Cubana Farm. 2012;46(3):329-42.
How to Cite
Downloads
Downloads
Published
How to Cite
Issue
Section
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
